00:00 / 00:00
0 / 21 complete
bevacizumab and p. 449
bevacizumab for p. 450
bevacizumab p. 450
bevacizumab for p. 449
With monoclonal antibodies, antibodies means that they target a specific antigen on the cell surface with an antibody-antigen binding; and monoclonal means that each antibody is produced from a specific B cell line consisting of identical B cells.
In this video, we are focusing on the monoclonal antibodies that are used for cancer.
Normally, all of our cells grow and divide through a tightly regulated cell cycle once they receive growth factor signals.
During the cell cycle, if a cell appears abnormal in any way to the immune cells that do constant surveillance, the cell has to fix the problem or undergo apoptosis, or programmed cell death - a bit like cellular suicide, rather than proceed to the next phase of the cell cycle.
But cells can become mutated due to environmental or genetic factors.
A mutated cell becomes cancerous when it starts to divide uncontrollably.
As cancer cells start piling up on each other, they form a small tumor mass and they need to induce blood vessel growth, called angiogenesis, to supply themselves with enough energy.
Some tumors produce vascular endothelial growth factor, or VEGF, which binds to VEGF receptors found on vascular endothelial cells and stimulates angiogenesis.
Also, many tumors overexpress growth factor receptors like the epidermal growth factor receptor, or EGFR, and the human epidermal receptor 2, or HER2, that stimulate cell proliferation and tumor growth.
Malignant tumors are ones that are able to break through the basement membrane.
Some of these malignant tumors go a step further and detach from their basement membrane at the primary tumor site, enter nearby blood vessels or the lymphatic system, and establish secondary sites of tumor growth throughout the body—a process called metastasis.
Now, the monoclonal antibodies that are used for the treatment of cancer target specific antigens that are usually overexpressed on the surface of cancer cells.
Monoclonal antibodies (mAbs) are laboratory-produced proteins that are designed to recognize and bind to specific molecules or cells in the body. They are produced by cloning a single type of immune cell and using the cells to produce large amounts of a specific antibody. Monoclonal antibodies have a variety of medical uses including treatment of cancers, autoimmune, and infectious diseases.
Copyright © 2023 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Cookies are used by this site.
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.